We provide a new generation
of tools to stimulate novel
applications at the forefront
of nanotechnology, in additive
manufacturing, in life sciences
Pascal Behr
Co-founder & CEO
make smart people think completely “Out of the Box”
rather than to let them remain trapped in their existing
object scale and product size paradigm. To overcome this
challenge, the company has developed multiple
relationships with universities and innovation department of
various companies.
This Swiss nanotechnology company comprises of a
heterogeneous team where experienced seniority meets
ambitious and well educated young specialists. At
Cytosurge, each employee is encouraged to participate in
the continuous “Culture at Cytosurge” – a program which
aims to actively build a culture every member can
recognize. The company works in an environment with lots
of freedom promoting natural self-responsibility.
About the Pillar of Cytosurge
Pascal Behr, Co- founder, and CEO of Cytosurge is
redefining technology and leading the industry. After
completing his engineering degree in Electricals and
Nanotechnology at ETH Zurich and Northwestern
University, USA, Pascal finished his doctoral studies in the
Laboratory of Biosensors and Bioelectronics at ETH Zurich
and started focusing his research on the combination of
atomic force microscopy with microfluidics; a technology
termed FluidFM. Pascal is a man of excellence. Along with
gaining an extreme level of academic knowledge, Pascal
has also co-invented several patents related to FluidFM
technology. He has been featured in numerous national and
international blog posts and newspaper articles as a co-
founder of Cytosurge.
| August 2017 |
and in single cell biology
Under Pascal’s guidance, Cytosurge has won various
prestigious awards like 2017 “Best Development in 3D
Printing” Award from ID TechEx in Berlin, Germany and
“Pionierpreis” presented by Zürcher Kantonalbank and
Technopark Zurich in 2012 which is the most prestigious
Startup award in Switzerland. Apart from leading the team
of Cytosurge, Pascal is a Board member in a private Swiss
industrial enterprise where he is responsible for innovation
and digital transformation.
Future of 3D Printing through the Eyes of Cytosurge
In general, the 3D printing sector is a fast-growing one and
it is important that Cytosurge provides value and benefit
due its ability to build very complex structures providing
clear technical advantages. Cytosurge said that the future of
3D printing using FluidFM is very different since the
technology is opening the possibility to build objects at a
significantly smaller scale than any other 3D metal printing
technique has achieved so far.
Cytosurge’s technologies are offering an additional future
benefit to the industry which gives businesses to parallelize
the printing process utilizing established semiconductor
manufacturing techniques. This possibility opens up new
doors regarding manufacturing which stand firm as a
difficult challenge for other 3D printing technologies.
35